Other languages NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
22.15 ^USD	-4.24%		-0.54%	+48.36%

Jun. 04	Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating	MT
Jun. 03	Novocure Announces the Presentation of Clinical Data from the Phase 3 Metis Trial	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novocure Announces the Presentation of Clinical Data from the Phase 3 Metis Trial	Jun. 03
TIGER-Studie berichtet über neue Überlebensergebnisse der TTFields-Therapie bei neu diagnostizierten Glioblastom-Patienten in Deutschland	May. 24
Novocure Releases Topline Efficacy and Safety Data from the TIGER Study Investigating the Use of Tumor Treating Fields Therapy in the Treatment of Patients with Newly Diagnosed Glioblastoma in Germany	May. 23
NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue	May. 02
BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	May. 02
BioPharma Credit agrees USD400 million loan for oncology firm Novacure	May. 02
NovoCure Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
NovoCure Limited Announces Results of the Metis Phase 3 Clinical Trial in Brain Metastases from Non-Small Cell Lung Cancer	Apr. 24
NovoCure Says New Data Show TTFields' Potential Therapeutic Effects in Pancreatic Cancer	Apr. 05
Klinische Phase-3-Studie METIS erreicht primären Endpunkt und zeigt eine statistisch signifikante Verlängerung der Zeit bis zur intrakraniellen Progression bei Patient:innen mit Hirnmetastasen von nicht-kleinzelligem Lungenkrebs	Mar. 28
L’essai clinique de phase 3 METIS a atteint son critère principal, démontrant un allongement statistiquement significatif du délai médian jusqu’à la progression intracrânienne chez les patients porteurs de métastases cérébrales consécutives...	Mar. 28
Aktien New York Schluss: Anleger greifen nach Rücksetzer wieder zu	Mar. 27
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	Mar. 27
Sector Update: Health Care Stocks Edge Higher Pre-Bell Wednesday	Mar. 27
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	Mar. 27
Sector Update: Health Care	Mar. 27
NovoCure Says Trial of Therapy for Brain Metastases From Lung Cancer Met Primary Endpoint; Shares Jump Pre-Bell	Mar. 27
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Board Governor Waller's Speech	Mar. 27
Novocure's lung cancer therapy succeeds in late-stage trial	Mar. 27
Novocure Q4 Net Loss Widens, Revenue Rises	Feb. 22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NovoCure Limited

Equities

NVCR

JE00BYSS4X48

Other languages

Filters